Applied pharmacoeconomics: Evaluation and use of pharmacoeconomic data from the literature

American Journal of Health-System Pharmacy

Volumn 56, Issue 16, 1999, Pages 1630-1640

  Sanchez, Lisa A ^a  

^a PE Applications Inc   (United States)

Author keywords

Administration; Economics; Methodology; Pharmacists, hospital; Pharmacoeconomics; Pharmacy, institutional, hospital

Indexed keywords

DRUG INDUSTRY; MEDICAL LITERATURE; PHARMACOECONOMICS; PHARMACY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

EID: 0033567212     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/56.16.1630     Document Type: Review

References (28)

1. Sanchez LA. Pharmacoeconomics: principles, methods, and applications to pharmacotherapy. In: Dipiro JT, Talbert RL, Yee GC et al., eds. Pharmacotherapy: a pathophysiologic approach. 4th ed. Stamford, CT: Appleton & Lange; 1999.
2. Sanchez LA. Some techniques for adapting pharmacoeconomics and outcomes research to pharmaceutical care. New Med. 1997; 1:41-5.
3. Jones AJ, Sanchez LA. Pharmacoeconomic evaluation: applications in managed care formulary decision making. Drug Benefit Trends. 1995; 7:12,15,19-22,32-4.
4. Lee JT, Sanchez LA. Interpretation of "cost-effective" and soundness of economic evaluations in the pharmacy literature. Am J Hosp Pharm. 1991; 48:2622-7.
5. Udvarhelyi IS, Colditz GA, Rai A et al. Cost effectiveness and cost benefit analyses in the medical literature. Ann Intern Med. 1992; 116:238-44.
6. Bradley CA, Iskedjian M, Lanctot KL et al. Quality assessment of economic evaluations in selected pharmacy, medical, and health economic journals. Ann Pharmacother. 1995; 29:681-9.
7. Drummond MF, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programmes. Oxford, England: Oxford Univ. Press; 1986:18-38:74-111.
8. Sacristan JA, Soto J, Galende I. Evaluation of pharmacoeconomic studies: utilization of a checklist. Ann Pharmacother. 1993;27:1126-33.
9. Eisenberg JM. Clinical economics. A guide to economic analysis of clinical practices. JAMA. 1989; 262:2879-86.
10. Jolicoeur LM, Jones-Grizzle AJ, Boyer JG. Guidelines for performing a pharmacoeconomic analysis. Am J Hosp Pharm. 1992; 49:1741-7.
11. Detsky AS. Guidelines for economic analysis of pharmaceutical products. Pharmacoeconomics. 1993; 3:354-61.
12. Bootman JL, Townsend RJ, McGhan WF. Principles of pharmacoeconomics. 2nd ed. Cincinnati: Harvey Whitney; 1996:213-27,279-89.
13. Clemens K, Townsend R, Luscombe F et al. Methodological and conduct principles for pharmacoeconomic research. Pharmacoeconomics. 1995; 8:169-74.
14. Task Force on Principles for Economic Analysis of Healthcare Technology. Economic analysis of healthcare technology: a report on principles. Ann Intern Med. 1995; 122:61-70.
15. Siegel JE, Torrance GW, Russell LB et al. Guidelines for pharmacoeconomic studies: recommendations from the Panel on Cost-Effectiveness in Health and Medicine. Pharmacoeconomics. 1997; 11:159-68.
16. Russell LB, Gold MR, Siegel JE et al. The role of cost-effectiveness analysis in health and medicine. JAMA. 1996; 276:1172-7.
17. Weinstein MC, Siegel JE, Gold MR et al. Recommendations of the Panel on Cost-Effectiveness in Health and Medicine. JAMA. 1996; 276:1253-8.
18. Siegel JE, Weinstein MC, Russell LB et al. Recommendations for reporting cost-effectiveness analyses. JAMA. 1996; 276: 1339-41.
19. Torrance GW, Blaker D, Detsky A et al. Canadian guidelines for economic evaluation of pharmaceuticals. Pharmacoeconomics. 1996; 9:535-59.
20. Iskedjian M, Trakas K, Bradley CA et al. Quality assessment of economic evaluations published in PharmacoEconomics: the first four years (1992 to 1995). Pharmacoeconomics. 1997; 12:685-94.
21. Sanchez LA. Evaluating the quality of published pharmacoeconomic evaluations. Hosp Pharm. 1995; 30:146-52.
22. Schumock GT, Meek PD, Ploetz PA et al. Economic evaluations of clinical pharmacy services - 1988-1995. Pharmacotherapy. 1996; 16:1188-208.
23. Einarson TR. Meta-analysis of the pharmacotherapy literature. In: Hartzema AG, Porta MS, Tilson HH, eds. Pharmacoepidemiology: an introduction. 2nd ed. Cincinnati: Harvey Whitney; 1991:236-69.
24. Garg R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA. 1995; 273:1450-6.
25. Cook DJ, Sackett DL, Spitzer WO. Methodologic guidelines for systematic reviews of randomized controlled trials in health care from the Potsdam consultation on meta-analysis. J Clin Epidemiol. 1995; 48:167-71.
26. Sackett DL, Haynes RB, Tugwell P. Clinical epidemiology: a basic science for clinical medicine. Boston: Little, Brown; 1985:126.
27. Barr JT, Schumacher GE. Applying decision analysis to pharmacy management and practice decisions. Top Hosp Pharm Manag. 1994; 13(4):60-71.
28. Mason J. The generalisability of pharmacoeconomic studies. Pharmacoeconomics. 1997; 11:503-14.